Real-world retrospective study of effectiveness and safety of FINgOlimod in relapsing remitting multiple sclerosis in the Middle East and North Africa (FINOMENA)

•Largest real-world study to date on effectiveness and safety of fingolimod in routine clinical practice in the Middle East and North Africa region.•Fingolimod was effective in reducing relapses and MRI activity and improving EDSS scores in RRMS patients.•Fingolimod’s effectiveness was sustained wit...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical neurology and neurosurgery 2021-04, Vol.203, p.106576-106576, Article 106576
Hauptverfasser:	Alroughani, Raed, AlKawi, Zuhair, Hassan, Ahmed, Al Otaibi, Hessa, Mujtaba, Ahmed, Al Atat, Rami, Riachi, Naji, Akkawi, Nabil, Koussa, Salam, Inshasi, Jihad, Alsaadi, Taoufik, Ahmed, Samar Farouk, Al-Aasmi, Abdullah, Zakaria, Magd, El Fadally, Haitham
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Adverse events Africa, Northern Age Clinical medicine Effectiveness FDA approval Female Fingolimod Fingolimod Hydrochloride - therapeutic use Gadolinium Humans Immunosuppressive Agents - therapeutic use Leukopenia Lymphopenia Magnetic resonance imaging Male Medical records Middle East Multiple sclerosis Multiple Sclerosis, Relapsing-Remitting - drug therapy Neurology Patients Performance evaluation Real-world evidence Retrospective Studies Safety Statistical analysis Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!